These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11937331)

  • 1. Comparison of the inhibition of human and Trypanosoma cruzi prolyl endopeptidases.
    Vendeville S; Goossens F; Debreu-Fontaine MA; Landry V; Davioud-Charvet E; Grellier P; Scharpe S; Sergheraert C
    Bioorg Med Chem; 2002 Jun; 10(6):1719-29. PubMed ID: 11937331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and activity of pyrrolidinyl- and thiazolidinyl-dipeptide derivatives as inhibitors of the Tc80 prolyl oligopeptidase from Trypanosoma cruzi.
    Joyeau R; Maoulida C; Guillet C; Frappier F; Teixeira AR; Schrével J; Santana J; Grellier P
    Eur J Med Chem; 2000 Feb; 35(2):257-66. PubMed ID: 10758287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of prolyl endopeptidase inhibitors and evaluation of their structure-activity relationships: in vitro inhibition of prolyl endopeptidase from canine brain.
    Arai H; Nishioka H; Niwa S; Yamanaka T; Tanaka Y; Yoshinaga K; Kobayashi N; Miura N; Ikeda Y
    Chem Pharm Bull (Tokyo); 1993 Sep; 41(9):1583-8. PubMed ID: 8221972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel Trypanosoma cruzi prolyl oligopeptidase inhibitors by structure-based virtual screening.
    de Almeida H; Leroux V; Motta FN; Grellier P; Maigret B; Santana JM; Bastos IM
    J Comput Aided Mol Des; 2016 Dec; 30(12):1165-1174. PubMed ID: 27770305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and structural characterization of an ecotin-like serine protease inhibitor from Trypanosoma cruzi.
    Garcia FB; Cabral AD; Fuhlendorf MM; da Cruz GF; Dos Santos JV; Ferreira GC; de Rezende BRC; Santana CM; Puzer L; Sasaki SD; Garcia W; Sperança MA
    Int J Biol Macromol; 2020 May; 151():459-466. PubMed ID: 32084472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New prolyl endopeptidase inhibitors: in vitro and in vivo activities of azabicyclo[2.2.2]octane, azabicyclo[2.2.1]heptane, and perhydroindole derivatives.
    Portevin B; Benoist A; Rémond G; Hervé Y; Vincent M; Lepagnol J; De Nanteuil G
    J Med Chem; 1996 Jun; 39(12):2379-91. PubMed ID: 8691432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated parallel synthesis of a tetrahydroisoquinolin-based library: potential prolyl endopeptidase inhibitors.
    Vendeville S; Bourel L; Davioud-Charvet E; Grellier P; Deprez B; Sergheraert C
    Bioorg Med Chem Lett; 1999 Feb; 9(3):437-42. PubMed ID: 10091698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plant phenolics as prolyl endopeptidase inhibitors.
    Lee SH; Jun M; Choi JY; Yang EJ; Hur JM; Bae K; Seong YH; Huh TL; Song KS
    Arch Pharm Res; 2007 Jul; 30(7):827-33. PubMed ID: 17703733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Oxacephem-based human chymase inhibitors: discovery of stable inhibitors in human plasma.
    Aoyama Y; Uenaka M; Konoike T; Iso Y; Nishitani Y; Kanda A; Naya N; Nakajima M
    Bioorg Med Chem Lett; 2000 Nov; 10(21):2403-6. PubMed ID: 11078188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationships of a new class of 1-oxacephem-based human chymase inhibitors.
    Aoyama Y; Uenaka M; Konoike T; Iso Y; Nishitani Y; Kanda A; Naya N; Nakajima M
    Bioorg Med Chem Lett; 2000 Nov; 10(21):2397-401. PubMed ID: 11078187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New potent prolyl endopeptidase inhibitors: synthesis and structure-activity relationships of indan and tetralin derivatives and their analogues.
    Tanaka Y; Niwa S; Nishioka H; Yamanaka T; Torizuka M; Yoshinaga K; Kobayashi N; Ikeda Y; Arai H
    J Med Chem; 1994 Jun; 37(13):2071-8. PubMed ID: 8027988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of potent, selective human granzyme B inhibitors that inhibit CTL mediated apoptosis.
    Willoughby CA; Bull HG; Garcia-Calvo M; Jiang J; Chapman KT; Thornberry NA
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2197-200. PubMed ID: 12127536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma cruzi prolyl oligopeptidase Tc80 is involved in nonphagocytic mammalian cell invasion by trypomastigotes.
    Grellier P; Vendeville S; Joyeau R; Bastos IM; Drobecq H; Frappier F; Teixeira AR; Schrével J; Davioud-Charvet E; Sergheraert C; Santana JM
    J Biol Chem; 2001 Dec; 276(50):47078-86. PubMed ID: 11598112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prolyl endopeptidase-inhibiting benzofuran dimer from Polyozellus multiflex.
    Song KS; Raskin I
    J Nat Prod; 2002 Jan; 65(1):76-8. PubMed ID: 11809072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of inhibitors of an 80 kDa protease from Trypanosoma cruzi through the screening of a combinatorial peptide library.
    Vendeville S; Buisine E; Williard X; Schrevel J; Grellier P; Santana J; Sergheraert C
    Chem Pharm Bull (Tokyo); 1999 Feb; 47(2):194-8. PubMed ID: 10071854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. kynapcin-13 and -28, new benzofuran prolyl endopeptidase inhibitors from polyozellus multiplex.
    Kim SI; Park IH; Song KS
    J Antibiot (Tokyo); 2002 Jul; 55(7):623-8. PubMed ID: 12243451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poststatin, a new inhibitor of prolyl endopeptidase. VII. N-cycloalkylamide analogues.
    Tsuda M; Muraoka Y; Nagai M; Aoyagi T; Takeuchi T
    J Antibiot (Tokyo); 1996 Sep; 49(9):909-20. PubMed ID: 8931725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular modeling studies of prolyl endopeptidase inhibitors].
    Kánai K; Fehér M; Lopata A; Podányi B; Novák I; Susán E; Hermecz I; Arányi P
    Acta Pharm Hung; 1999 Nov; 69(5):240-6. PubMed ID: 10652791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of bisbenzamidines as inhibitors for matriptase-2.
    Beckmann AM; Gilberg E; Gattner S; Huang TL; Vanden Eynde JJ; Mayence A; Bajorath J; Stirnberg M; Gütschow M
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3741-5. PubMed ID: 27287367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dibasic inhibitors of human mast cell tryptase. Part 2: structure-activity relationships and requirements for potent activity.
    Rice KD; Wang VR; Gangloff AR; Kuo EY; Dener JM; Newcomb WS; Young WB; Putnam D; Cregar L; Wong M; Simpson PJ
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2361-6. PubMed ID: 11055356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.